Biotechnology and Genomics

This is Unit Seven of Biology, Part Two: mapping, sequencing, and the -omics. Two kinds of map open the part, and they measure different quantities. A genetic map gives distances derived from recombination frequency, in map units. A physical map gives distances counted in nucleotides. Both give gene order — what differs is the unit and the resolution, which is why a complete map integrates the two. Then sequencing. Sanger chemistry stops synthesis wherever a dideoxynucleotide is incorporated, and the fluorescent label on each one is what makes the resulting ladder readable. Next-generation sequencing did not replace that chemistry — the word names automation and scale, many fragments read at once. The walkthrough makes a point worth holding: assembly produces a raw sequence and nothing more. Annotation, attaching known gene identities to positions, is a separate later step, and an unannotated genome carries no labelled meaning. Then health, where the standing error is reading a risk result as a diagnosis. Most common disease is polygenic and environmentally modulated, so a flagged variant shifts probability rather than settling anything — and a clean result guarantees nothing either. By the end you will be able to do five things. One: say what each map measures. Two: say what stops a Sanger read. Three: say why assembly is not enough. Four: say why risk is not diagnosis. Five: say why a genome underdetermines a proteome.

Five entries. Two map types measuring different quantities, the landmarks used to build them, three methods with different precision, and the entry explaining why a complete map needs both kinds.

Counted in bases.

Bio 1559 The Physical Map

A physical map represents distance in nucleotides between genes or markers along a chromosome, complementing the recombination-based genetic map — it states a gene's distance from a marker in base pairs where a genetic map states it in recombination-derived map units.

The landmarks.

Bio 1561 Genetic Markers: RFLP, VNTR, and SNP

A genetic marker is a variable D N A sequence used to track chromosomal location, and three common types differ in what varies — one reads fragment lengths after restriction cutting, another a single varying nucleotide position. All three name kinds of sequence variation used as landmarks; none is itself a disease-causing mutation.

Three methods.

Bio 1563 Physical Mapping Methods: Cytogenetic, Radiation Hybrid, and Sequence Mapping

Physical maps are built by cytogenetic mapping of stained chromosomes, radiation hybrid mapping of fragmented D N A, or sequence mapping from sequence data. The three trade precision against data source: cytogenetic mapping gives an approximate chromosomal position, sequence mapping an exact base-pair one.

A known address.

Bio 1565 Sequence-Tagged Sites

A sequence-tagged site is a short D N A sequence with a known, unique chromosomal location, used as a landmark for sequence mapping — an expressed sequence tag from a complementary D N A library is one example. It is defined by its unique known location, not by any biological function of the sequence itself.

Combining them.

Bio 1567 Integrating Genetic and Physical Maps

A complete genome map combines a genetic map's gene order with a physical map's nucleotide distances, since each alone leaves gaps — a sequence-tagged site links a genetic marker to an exact physical position. Both map types include order; they differ only in distance units and resolution.

Six entries. The chemistry that reads one fragment, three strategies for handling many, a choice about how much of a genome to read, and a walkthrough joining them. The walkthrough's warning is the one to carry out of the topic.

Stopping synthesis.

Bio 1569 Sanger Chain-Termination Sequencing

Sanger chain-termination sequencing, developed in the nineteen seventies, reads D N A using fluorescently labelled dideoxynucleotides that halt replication wherever incorporated — a dideoxynucleotide lacks the hydroxyl group needed to attach the next one. The fluorescent label on each, rather than position alone, is what lets the resulting ladder be read back into a sequence.

Random fragments.

Bio 1571 Shotgun Sequencing and Contigs

Shotgun sequencing breaks many genome copies into random overlapping fragments, sequences each, and reassembles them into a contig by matching overlaps — two fragments sharing an identical overlapping end join into one longer stretch. A contig is only as reliable as its overlaps; too few fragments in a region leaves a gap no contig can close.

Both ends.

Bio 1573 Pairwise-End Sequencing

Pairwise-end sequencing reads both ends of each fragment rather than one, supplying more overlap information for reassembling larger genomes — knowing a fragment's start and end constrains where it fits more tightly than one end alone. It yields more information per fragment, at the cost of more sequencing reactions.

Many at once.

Bio 1575 Next-Generation Sequencing's Parallel Structure

Next-generation sequencing automates rapid, parallel sequencing of huge numbers of short fragments at once, with software assembling the results into contigs. Parallel means many fragments read simultaneously, not a faster read of one long fragment — the term names automation and scale rather than a replacement for Sanger's chemistry.

How much to read.

Bio 1577 Whole-Genome versus Whole-Exome Sequencing

Whole-genome sequencing determines an organism's entire D N A sequence, while whole-exome sequencing determines only the protein-coding exon regions, skipping introns and non-coding D N A. Whole-exome covers a smaller fraction by design — it is not a lower-resolution read of the same regions.

Fragments to a usable genome.

Bio 1579 Tracing Fragments to an Assembled, Annotated Genome Sequence

The walkthrough runs many genome copies broken into overlapping fragments, each read by chain-termination chemistry, with both ends sequenced where single-end overlaps leave ambiguity, and automated sequencers applying that chemistry to enormous numbers at once. Software matches overlapping ends into progressively longer contigs spanning the genome. Then a separate step: researchers attach known gene identities to positions, which is annotation. Assembly produces a raw sequence; an unannotated genome carries no labelled meaning.

One entry, and its warning is the standing caution about sequence comparison. Finding a match tells you about similarity at the region searched, and stops there.

Finding matches.

Bio 1581 Sequence Alignment and BLAST

Sequence alignment arranges D N A, R N A or protein sequences to identify shared regions, and search software returns every location in a chosen genome with a closely matching sequence to a query. A match shows sequence similarity at the searched region; it does not establish identical function.

Three entries, and they are why this lecture carries the medical disclaimer. The middle one is a misconception entry placed directly between the two it governs, and its correction runs in both directions.

Many genes at once.

Bio 1583 Polygenic Disease Risk from Genome Analysis

A polygenic disease's risk depends on multiple genes plus environment, so genome analysis yields an estimated risk pattern rather than a determined outcome — it can flag which contributing variants a genome carries without any one of them determining anything. Single-gene defects cause only a small fraction of common disease.

The standing error.

Bio 1585 "A Genetic Risk Result Is a Diagnosis"

A genomic risk result is not a diagnosis, because most common diseases are polygenic and environmentally modulated, so a flagged variant shifts probability rather than establishing certainty — two people carrying the same variant may never develop the same condition. And a clean result does not guarantee the disease will never develop.

Genome and drug.

Bio 1587 Pharmacogenomics

Pharmacogenomics evaluates how an individual's genome relates to a drug's effectiveness and safety, informing which treatments a gene profile suggests testing — a gene-expression change after drug exposure in a lab model can signal potential toxicity. It predicts response from the genome, which is not the same as testing the drug itself for safety in trials.

Three entries widening the frame. A whole microbial community sequenced without culturing anything, one small genome that traces a single parental line, and a field application whose warning is about what a finding does not accomplish.

A whole community.

Bio 1589 Metagenomics

Metagenomics studies the collective genomes of multiple species growing together in an environmental niche, without first isolating each in pure culture — sequencing D N A extracted directly from soil identifies species that pure-culture methods would miss. It works on combined genetic material directly.

One line.

Bio 1591 Mitochondrial Genomics

Mitochondrial genomics studies mitochondrial D N A, which mutates rapidly and passes from mother to offspring, making it useful for tracing genealogy and evolution — following that sequence across generations reconstructs a maternal-line genealogy. It does not track paternal-line ancestry the way nuclear markers can.

In the field.

Bio 1593 Genomics in Agriculture

Genomics identifies which genes underlie a desirable agricultural trait, letting researchers transfer it between organisms more directly than traditional breeding — identifying the genes behind drought tolerance in one variety opens the way toward a sensitive one. Identifying a trait's genes is the genomic finding; transferring the trait still needs the engineering techniques from Part One.

Five entries. A genome is not the last word, and this topic is the argument for why. The proteome is what a cell actually produces, and the misconception entry explains what the sequence alone leaves undetermined.

What a cell makes.

Bio 1595 The Proteome

A proteome is the entire set of proteins a given cell type produces, and unlike the genome it is dynamic and cell-type-specific — a liver cell and a neuron share a genome and produce different proteomes. It is what a cell actually produces, not what its genome could produce; expression rather than gene presence determines it.

The standing error.

Bio 1597 "The Genome Fully Predicts the Proteome"

A genome does not fully predict its proteome, because alternative splicing and post-translational modification add diversity the sequence alone does not fix — splicing one gene's transcript produces more than one protein. The genome sets which proteins are possible; splicing and modification determine which a cell actually makes.

Three questions.

Bio 1599 Techniques for Protein Analysis

Mass spectrometry identifies a protein's mass and characteristics; X-ray crystallography and nuclear magnetic resonance determine three-dimensional structure; two-hybrid screening detects protein-protein interactions. The three answer different questions — identity, structure and interaction are not interchangeable measurements.

The whole network.

Bio 1601 Systems Biology

Systems biology studies whole biological systems, such as a genome or proteome, based on interactions among many components rather than one alone — mapping how a network of interacting proteins shifts together under one condition. It focuses on the interaction network and does not replace the single-component studies its findings depend on.

The small molecules.

Bio 1603 Metabolomics

Metabolomics studies an organism's metabolome — the complete set of small-molecule metabolites related to its genetic makeup — comparing genotype against physical and environmental factors. It catalogues small-molecule metabolites specifically, a distinct level from the genome's sequence and the proteome's protein set.

One capstone joining everything: both map types, the sequencing and assembly walkthrough, the central dogma from Unit Six, and the protein-analysis techniques. Its warning names two stages and refuses to let either stand in for the other.

The capstone. Gene to trait.

Bio 1605 Tracing a Trait from a Sequenced Gene to Proteome-Level Function

The capstone starts from a gene located approximately by a genetic map and exactly by a physical map, found within an assembled and annotated sequence. The central dogma then carries it to protein — transcription, processing, translation. But the trail does not end there: because a proteome is dynamic, the same transcript may be spliced into more than one form and modified afterward, so one sequenced gene does not correspond to one fixed protein. Determining what the products actually do needs direct analysis — mass, structure and interaction. Locating a sequence is not characterising a protein; a complete trace needs both.

Five things to carry out of Part Two, and out of Unit Seven. A genetic map measures distance in recombination-derived map units; a physical map measures it in nucleotides counted directly. Both give gene order, so the difference is unit and resolution rather than kind — which is why a complete genome map integrates the two, with sequence-tagged sites linking a genetic marker to an exact physical position. A dideoxynucleotide halts synthesis because it lacks the hydroxyl group needed to attach the next nucleotide, and its fluorescent label is what makes the resulting fragment ladder readable. Next-generation sequencing names automation and scale — many short fragments read in parallel — rather than a different chemistry. Assembly alone does not make a genome useful. Matching overlaps joins fragments into contigs and produces a raw sequence, and that sequence says nothing about what any of it does. Annotation is a separate later step attaching known gene identities to positions. A genetic risk result is not a diagnosis. Most common diseases are polygenic and shaped by environment, so a flagged variant shifts probability rather than settling an outcome — two people carrying the same variant may never develop the same condition. A clean result guarantees nothing either. And a genome does not fully predict a proteome. The genome sets which proteins are possible; alternative splicing produces more than one protein from a single gene, and post-translational modification changes them further. A proteome is what a cell actually produces, which is why it differs between a liver cell and a neuron carrying identical D N A. Unit Eight turns to evolutionary processes.